AB&Company Co.,Ltd.

TSE:9251 Voorraadrapport

Marktkapitalisatie: JP¥13.2b

AB&CompanyLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

AB&CompanyLtd has a total shareholder equity of ¥8.3B and total debt of ¥7.9B, which brings its debt-to-equity ratio to 96.1%. Its total assets and total liabilities are ¥24.9B and ¥16.6B respectively. AB&CompanyLtd's EBIT is ¥1.8B making its interest coverage ratio 12.6. It has cash and short-term investments of ¥2.4B.

Belangrijke informatie

96.1%

Verhouding schuld/eigen vermogen

JP¥7.94b

Schuld

Rente dekkingsratio12.6x
ContantJP¥2.36b
AandelenJP¥8.26b
Totaal verplichtingenJP¥16.65b
Totaal activaJP¥24.91b

Recente financiële gezondheidsupdates

Recent updates

These 4 Measures Indicate That AB&CompanyLtd (TSE:9251) Is Using Debt Reasonably Well

Aug 05
These 4 Measures Indicate That AB&CompanyLtd (TSE:9251) Is Using Debt Reasonably Well

We Like The Quality Of AB&CompanyLtd's (TSE:9251) Earnings

Jun 21
We Like The Quality Of AB&CompanyLtd's (TSE:9251) Earnings

Analyse van de financiële positie

Kortlopende schulden: 9251's short term assets (¥4.2B) do not cover its short term liabilities (¥5.4B).

Langlopende schulden: 9251's short term assets (¥4.2B) do not cover its long term liabilities (¥11.2B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 9251's net debt to equity ratio (67.6%) is considered high.

Schuld verminderen: Insufficient data to determine if 9251's debt to equity ratio has reduced over the past 5 years.

Schuldendekking: 9251's debt is well covered by operating cash flow (36.9%).

Rentedekking: 9251's interest payments on its debt are well covered by EBIT (12.6x coverage).


Balans


Ontdek gezonde bedrijven